Literature DB >> 26047790

Renal Clearance of Mineral Metabolism Biomarkers.

Adriana J van Ballegooijen1, Eugene P Rhee2, Sammy Elmariah3, Ian H de Boer4, Bryan Kestenbaum4.   

Abstract

CKD leads to disturbances in multiple interrelated hormones that regulate bone and mineral metabolism. The renal handling of mineral metabolism hormones in humans is incompletely understood. We determined the single-pass renal clearance of parathyroid hormone, fibroblast growth factor 23, vitamin D metabolites, and phosphate from paired blood samples collected from the abdominal aorta and renal vein in 17 participants undergoing simultaneous right and left heart catheterization and estimated associations of eGFR with the renal elimination of metabolites. The mean age ±SD of the study population was 71.4±10.0 years and 11 participants (65%) were male. We found a relatively large mean±SD single-pass renal extraction of parathyroid hormone (44.2%±10.3%) that exceeded the extraction of creatinine (22.1%±7.9%). The proportionate renal extraction of parathyroid hormone correlated with eGFR. The renal extraction of fibroblast growth factor 23 was, on average, lower than that of parathyroid hormone with greater variability across individuals (17.1%±19.5%). There were no differences in the mean concentrations of vitamin D metabolites across the renal vein and artery. In summary, we demonstrate substantial single-pass renal extraction of parathyroid hormone at a rate that exceeds glomerular filtration. Impaired renal clearance of parathyroid hormone may contribute to secondary hyperparathyroidism in CKD.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  extraction; mineral metabolism biomarkers; renal clearance

Mesh:

Substances:

Year:  2015        PMID: 26047790      PMCID: PMC4731122          DOI: 10.1681/ASN.2014121253

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  21 in total

Review 1.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

2.  The renal handling of parathyroid hormone. Role of peritubular uptake and glomerular filtration.

Authors:  K J Martin; K A Hruska; J Lewis; C Anderson; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

Review 3.  Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Authors:  T Maack; V Johnson; S T Kau; J Figueiredo; D Sigulem
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

4.  Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.

Authors:  Pablo Ureña-Torres; Marie Metzger; Jean Philippe Haymann; Alexandre Karras; Jean-Jacques Boffa; Martin Flamant; François Vrtovsnik; Cédric Gauci; Marc Froissart; Pascal Houillier; Bénédicte Stengel
Journal:  Am J Kidney Dis       Date:  2011-07-31       Impact factor: 8.860

5.  Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.

Authors:  Tamara Isakova; Huiliang Xie; Allison Barchi-Chung; Gabriela Vargas; Nicole Sowden; Jessica Houston; Patricia Wahl; Andrew Lundquist; Michael Epstein; Kelsey Smith; Gabriel Contreras; Luis Ortega; Oliver Lenz; Patricia Briones; Phyllis Egbert; T Alp Ikizler; Harald Jueppner; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 8.237

6.  FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.

Authors:  Sangeeta Pande; Cynthia S Ritter; Marcos Rothstein; Karen Wiesen; John Vassiliadis; Rajiv Kumar; Susan C Schiavi; Eduardo Slatapolsky; Alex J Brown
Journal:  Nephron Physiol       Date:  2006-05-10

Review 7.  FGF-23 and secondary hyperparathyroidism in chronic kidney disease.

Authors:  Justin Silver; Tally Naveh-Many
Journal:  Nat Rev Nephrol       Date:  2013-07-23       Impact factor: 28.314

8.  Parathyroid hormone clearance in man.

Authors:  S B Oldham; E J Finck; F R Singer
Journal:  Metabolism       Date:  1978-08       Impact factor: 8.694

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  FGF-23 Levels before and after Renal Transplantation.

Authors:  Domniki Economidou; Spyros Dovas; Aikaterini Papagianni; Panagiotis Pateinakis; Dimitrios Memmos
Journal:  J Transplant       Date:  2009-05-17
View more
  18 in total

1.  The effect of different protease inhibitors on stability of parathyroid hormone, insulin, and prolactin levels under different lag times and storage conditions until analysis.

Authors:  Ozgur Baykan; Ali Yaman; Fethullah Gerin; Onder Sirikci; Goncagul Haklar
Journal:  J Clin Lab Anal       Date:  2017-01-30       Impact factor: 2.352

Review 2.  Potential application of klotho in human chronic kidney disease.

Authors:  Javier A Neyra; Ming Chang Hu
Journal:  Bone       Date:  2017-01-20       Impact factor: 4.398

3.  Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.

Authors:  David E Leaf; Kirolos A Jacob; Anand Srivastava; Margaret E Chen; Marta Christov; Harald Jüppner; Venkata S Sabbisetti; Aline Martin; Myles Wolf; Sushrut S Waikar
Journal:  J Am Soc Nephrol       Date:  2016-12-27       Impact factor: 10.121

Review 4.  New concepts in regulation and function of the FGF23.

Authors:  Sanaz Dastghaib; Farhad Koohpeyma; Mesbah Shams; Forough Saki; Aliakbar Alizadeh
Journal:  Clin Exp Med       Date:  2022-06-16       Impact factor: 3.984

Review 5.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

6.  Abnormalities in biomarkers of mineral and bone metabolism in kidney donors.

Authors:  Bertram L Kasiske; Rajiv Kumar; Paul L Kimmel; Todd E Pesavento; Roberto S Kalil; Edward S Kraus; Hamid Rabb; Andrew M Posselt; Teresa L Anderson-Haag; Michael W Steffes; Ajay K Israni; Jon J Snyder; Ravinder J Singh; Matthew R Weir
Journal:  Kidney Int       Date:  2016-06-28       Impact factor: 10.612

Review 7.  Fibroblast Growth Factor 23 and αKlotho in Acute Kidney Injury: Current Status in Diagnostic and Therapeutic Applications.

Authors:  Javier A Neyra; Ming Chang Hu; Orson W Moe
Journal:  Nephron       Date:  2020-08-25       Impact factor: 2.847

8.  Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.

Authors:  David A Drew; Ronit Katz; Stephen Kritchevsky; Joachim H Ix; Michael G Shlipak; Anne B Newman; Andy Hoofnagle; Linda Fried; Mark J Sarnak; Orlando M Gutierrez
Journal:  Am J Nephrol       Date:  2018-04-05       Impact factor: 3.754

9.  Association of tubular solute clearances with the glomerular filtration rate and complications of chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

Authors:  Yan Chen; Leila R Zelnick; Ke Wang; Ronit Katz; Andrew N Hoofnagle; Jessica O Becker; Chi-Yuan Hsu; Alan S Go; Harold I Feldman; Rupal C Mehta; James P Lash; Sushrut S Waikar; L Hamm; Jing Chen; Tariq Shafi; Bryan R Kestenbaum
Journal:  Nephrol Dial Transplant       Date:  2020-11-17       Impact factor: 5.992

10.  Intact and C-Terminal FGF23 Assays-Do Kidney Function, Inflammation, and Low Iron Influence Relationships With Outcomes?

Authors:  Shilpa Sharma; Ronit Katz; Alexander L Bullen; Paulo H M Chaves; Peter W de Leeuw; Abraham A Kroon; Alfons J H M Houben; Michael G Shlipak; Joachim H Ix
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.